Skip to content

Randomized controlled trial to assess the volume reduction of the lower leg of subjects with chronic venous insufficiency under two different compression treatments

Randomized controlled trial to assess the volume reduction of the lower leg of subjects with chronic venous insufficiency under two different compression treatments - CLIN-PROT-EU-05-231200

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00008829
Enrollment
24
Registered
2015-06-22
Start date
2015-06-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I87.2

Interventions

Group 1: Compression System (Coban Fit) - Measurement of oedema reduction after 24 hours , measurement of ankle joint mobility with and without compression product Group 2: Short-Stretch Bandage (Rosi

Sponsors

3M Deutschland GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Mobile males or females, age 18 years or older 2.Subjects having a chronic venous insufficiency (stage C3-C5 according to CEAP classification) 3.Subjects have pitting oedema 4.Duplex investigation proving superficial or deep obstruction and /or reflux 5.Subject has good joint mobility allowing exercises requested by the protocol 6.Subject has an Ankle Brachial Pressure Index ABPI (Ankle Brachial Pressure Index) = 0.8 7.Willing to give written informed consent and willing to comply with the study protocol

Exclusion criteria

Exclusion criteria: 1.Known pregnancy 2.Active leg ulcer 3.Peripheral arterial occlusive disease 4.Wearing of compression stockings less than 2 days prior to the scheduled study visits 5.Deep vein thrombosis in the last six months 6.Active cardiac disease or significant history of cardiac disease, 7.No change in oedema-reducing therapy (e.g. diuretics) one week before study start 8.Subjects who were, in the opinion of the investigator, unsuitable for enrolment in this study, for reasons not specified in the exclusion criteria. 9.Participation in any other prospective clinical study that can potentially interfere with this study

Design outcomes

Primary

MeasureTime frame
Measurement of % volume reduction between start and after 24 hours with water displacement volumetry

Secondary

MeasureTime frame
Goniometer measurement of ankle joint mobility with and without compression product directly before and after application of the product

Countries

Germany

Contacts

Public ContactWolfgang Vanscheidt

Dermatologie Freiburg

wolfgangvanscheidt@t-online.de0761-1377950

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026